Gracell Biotechnologies
As a member of the AstraZeneca Group, Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing novel autologous and allogeneic cell therapies for cancer and autoimmune diseases. Since its inception, Gracell has established a solid inhouse R&D system. Leveraging its proprietary FasTCAR and TruUCAR technology platforms and SMART CART™ technology modules, Gracell is researching new ways to address current challenges with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal T cell quality and barriers that limit their activity in solid tumors and autoimmune diseases.
7-day free trial · no credit card
Verified contacts
29
available on Kipplo
LinkedIn employees
37
201 to 500 range
Open roles
—
no listings
Distinct roles
25
indexed titles
Tech stack
3
tools in use
Monthly traffic
363
organic / mo
Sign up free to see all 29 verified contacts at Gracell Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
29 contacts with verified email or phone · masked until revealed.
- SN
Sophia Ng
Sr Legal Director · Other
EmailPhone - WY
Wenjie Yin
Senior Research Director · Other
EmailPhone
Showing 2 of 29 verified contacts
Top roles at Gracell Biotechnologies
25 distinct titles indexed · top 10 shown.
- 1clinical operations
- 1clinical project manager
- 1executive manager, public relations, china
- 1head of it
- 1head of operation and project management
- 1hrm
- 1ip
- 1it manager
- 1preclinical development director
- 1qc compliance and support manager
- +15more titles
Sign up to unlock all 29 contacts at Gracell Biotechnologies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 29 verified contacts at Gracell Biotechnologies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.